LinkedIn Profile

Access Juneau Biosciences historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:juneaubiosciences 380995 Dec 3rd, 2020 12:00AM Juneau Biosciences 109 11.00 Open Research Dec 3rd, 2020 11:08AM Dec 3rd, 2020 11:08AM Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care. Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions. Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries. Open womens health, research, endometriosis, preterm labor, preterm birth, genetics, obgyn Open 2749 East Parleys Way, Suite 200 Salt Lake City UT US 84109 Juneau Biosciences Pharmaceuticals & Biotechnology
private:juneaubiosciences 380995 Dec 2nd, 2020 12:00AM Juneau Biosciences 109 11.00 Open Research Dec 2nd, 2020 01:29PM Dec 2nd, 2020 01:29PM Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care. Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions. Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries. Open womens health, research, endometriosis, preterm labor, preterm birth, genetics, obgyn Open 2749 East Parleys Way, Suite 200 Salt Lake City UT US 84109 Juneau Biosciences Pharmaceuticals & Biotechnology
private:juneaubiosciences 380995 Dec 1st, 2020 12:00AM Juneau Biosciences 109 11.00 Open Research Dec 1st, 2020 01:05PM Dec 1st, 2020 01:05PM Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care. Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions. Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries. Open womens health, research, endometriosis, preterm labor, preterm birth, genetics, obgyn Open 2749 East Parleys Way, Suite 200 Salt Lake City UT US 84109 Juneau Biosciences Pharmaceuticals & Biotechnology
private:juneaubiosciences 380995 Nov 30th, 2020 12:00AM Juneau Biosciences 109 11.00 Open Research Nov 29th, 2020 07:10PM Nov 30th, 2020 01:56PM Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care. Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions. Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries. Open womens health, research, endometriosis, preterm labor, preterm birth, genetics, obgyn Open 2749 East Parleys Way, Suite 200 Salt Lake City UT US 84109 Juneau Biosciences Pharmaceuticals & Biotechnology
private:juneaubiosciences 380995 Nov 28th, 2020 12:00AM Juneau Biosciences 109 11.00 Open Research Nov 28th, 2020 02:46PM Nov 28th, 2020 02:46PM Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care. Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions. Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries. Open womens health, research, endometriosis, preterm labor, preterm birth, genetics, obgyn Open 2749 East Parleys Way, Suite 200 Salt Lake City UT US 84109 Juneau Biosciences Pharmaceuticals & Biotechnology
private:juneaubiosciences 380995 Nov 27th, 2020 12:00AM Juneau Biosciences 109 11.00 Open Research Nov 27th, 2020 11:10AM Nov 27th, 2020 11:10AM Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care. Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions. Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries. Open womens health, research, endometriosis, preterm labor, preterm birth, genetics, obgyn Open 2749 East Parleys Way, Suite 200 Salt Lake City UT US 84109 Juneau Biosciences Pharmaceuticals & Biotechnology
private:juneaubiosciences 380995 Nov 26th, 2020 12:00AM Juneau Biosciences 109 11.00 Open Research Nov 26th, 2020 12:09PM Nov 26th, 2020 12:09PM Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care. Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions. Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries. Open womens health, research, endometriosis, preterm labor, preterm birth, genetics, obgyn Open 2749 East Parleys Way, Suite 200 Salt Lake City UT US 84109 Juneau Biosciences Pharmaceuticals & Biotechnology
private:juneaubiosciences 380995 Nov 25th, 2020 12:00AM Juneau Biosciences 109 11.00 Open Research Nov 25th, 2020 05:27PM Nov 25th, 2020 05:27PM Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care. Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions. Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries. Open womens health, research, endometriosis, preterm labor, preterm birth, genetics, obgyn Open 2749 East Parleys Way, Suite 200 Salt Lake City UT US 84109 Juneau Biosciences Pharmaceuticals & Biotechnology
private:juneaubiosciences 380995 Nov 24th, 2020 12:00AM Juneau Biosciences 109 11.00 Open Research Nov 24th, 2020 12:40PM Nov 24th, 2020 12:40PM Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care. Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions. Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries. Open womens health, research, endometriosis, preterm labor, preterm birth, genetics, obgyn Open 2749 East Parleys Way, Suite 200 Salt Lake City UT US 84109 Juneau Biosciences Pharmaceuticals & Biotechnology
private:juneaubiosciences 380995 Nov 23rd, 2020 12:00AM Juneau Biosciences 109 11.00 Open Research Nov 23rd, 2020 02:45PM Nov 23rd, 2020 02:45PM Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care. Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions. Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries. Open womens health, research, endometriosis, preterm labor, preterm birth, genetics, obgyn Open 2749 East Parleys Way, Suite 200 Salt Lake City UT US 84109 Juneau Biosciences Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.